Global Recombinant Non-Glycosylated Proteins Biosimilars Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Recombinant Non-Glycosylated Proteins Biosimilars Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Recombinant Non-Glycosylated Proteins Biosimilars
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Recombinant Non-Glycosylated Proteins Biosimilars Market by Type

• 3.1 By Type
  • 3.1.1 Insulin
  • 3.1.2 rHGH
  • 3.1.3 Interferon
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Recombinant Non-Glycosylated Proteins Biosimilars Sandoz (Company Profile, Sales Data etc.)

• 4.2 Pfizer (Company Profile, Sales Data etc.)
• 4.3 Teva Pahrmaceutical (Company Profile, Sales Data etc.)
• 4.4 Celltrion (Company Profile, Sales Data etc.)
• 4.5 Biocon (Company Profile, Sales Data etc.)
• 4.6 Amgen (Company Profile, Sales Data etc.)
• 4.7 Samsung Biologics (Company Profile, Sales Data etc.)
• 4.8 Mylan (Company Profile, Sales Data etc.)
• 4.9 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
• 4.10 Stada Arzneimittel AG (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Oncology
  • 6.1.2 Demand in Chronic Diseases
  • 6.1.3 Demand in Autoimmune Diseases
  • 6.1.4 Demand in Blood Disorders
  • 6.1.5 Demand in Growth Hormone Deficiency
  • 6.1.6 Demand in Infectious Diseases
  • 6.1.7 Demand in Other Diseases
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Recombinant Non-Glycosylated Proteins Biosimilars

Table Application Segment of Recombinant Non-Glycosylated Proteins Biosimilars

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2013-2024, by Application, in USD Million

Table Major Company List of Insulin

Table Major Company List of rHGH

Table Major Company List of Interferon

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2013-2018, by Type, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2013-2018, by Type, in Volume

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2019-2024, by Type, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2019-2024, by Type, in Volume

Table Sandoz Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pahrmaceutical Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Teva Pahrmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celltrion Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biocon Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Samsung Biologics Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Samsung Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mylan Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy’s Laboratories Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Stada Arzneimittel AG Overview List

Table Recombinant Non-Glycosylated Proteins Biosimilars Business Operation of Stada Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue 2013-2018, by Company, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Revenue Share, by Company, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume 2013-2018, by Company, in Volume

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2019-2024, by Application, in USD Million

Table Recombinant Non-Glycosylated Proteins Biosimilars Demand Forecast 2019-2024, by Application, in Volume

Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2013-2018, by Region, in USD Million

Table Recombinant Non-Glycosylated Proteins Biosimilars Production 2013-2018, by Region, in Volume

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2013-2018, by Region, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2013-2018, by Region, in USD Million

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market 2013-2018, by Region, in Volume

Table Global Recombinant Non-Glycosylated Proteins Biosimilars Market Share 2013-2018, by Region, in Volume

Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in USD Million

Table North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in Volume

Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in Volume

Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in USD Million

Table South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size 2013-2018, by Country, in Volume

Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2019-2024, by Region, in USD Million

Table Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2013-2018, by Type, in USD Million

Figure Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth 2013-2018, by Type, in Volume

Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2018

Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Market Concentration, in 2018

Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars MMarket Concentration, in 2018

Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2018

Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration, in 2018

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Oncology, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Oncology, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Chronic Diseases, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Chronic Diseases, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Autoimmune Diseases, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Autoimmune Diseases, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Blood Disorders, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Blood Disorders, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Growth Hormone Deficiency, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Growth Hormone Deficiency, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Infectious Diseases, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Infectious Diseases, 2013-2018, in Volume

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Other Diseases, 2013-2018, in USD Million

Figure Recombinant Non-Glycosylated Proteins Biosimilars Demand in Other Diseases, 2013-2018, in Volume

Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure North America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in Volume

Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Europe Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in Volume

Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure South America Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Recombinant Non-Glycosylated Proteins Biosimilars Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview